Insulin Therapy Center

Recently a pump user reported a sudden increase in her glucose levels lasting a couple of days. Her blood sugars were elevated to 275-320mg/dL, with no ketones present.  Changing her infusion sets did not help. Nor did rotating to a new injection site or even using a fresh vial of insulin. After reviewing her insulin pump we noticed a symbol on her “home screen” saying that a special feature was running.

50-80% basal rate reduction lowers the risk of exercise-induced hypoglycemia.

Intensive insulin-adherence interventions that target type 2 diabetes patients with high risk of noncompliance can be beneficial.

New evidence suggests added consideration of the protein and fat.

Reusable smart insulin pens to launch first, followed by Bluetooth attachment for disposable pens later in 2019.

Trial examines differences in glycemic control and quality of life when using different insulin delivery methods.

High cost associated with underuse in certain patient populations, particularly those with lower incomes.

How does the newest insulin delivery method compare to an established system?

Study tests new closed-loop control technology using new Control-IQ algorithm.

With pressure from patients, elected representatives and the medical community, we are finally seeing some positive results in lowering the cost of a life-sustaining drug.